Astrana Health, Inc. (FRA:3AM)
Germany flag Germany · Delayed Price · Currency is EUR
20.60
-1.80 (-8.04%)
Last updated: Jan 27, 2026, 3:25 PM CET

Astrana Health Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Revenue
25.6513.9838.6841.0935.9634.85
Other Revenue
2,8712,0211,3481,103737.96652.33
2,8962,0351,3871,144773.92687.18
Revenue Growth (YoY)
68.17%46.72%21.19%47.84%12.62%22.57%
Cost of Revenue
2,5991,7631,172944.69596.14539.21
Gross Profit
296.97271.39214.96199.48177.77147.97
Selling, General & Admin
178.24154.11112.677.6762.0849.12
Operating Expenses
215.72182.04130.3595.2179.5967.47
Operating Income
81.2589.3584.61104.2798.1880.5
Interest Expense
-40.48-33.1-16.1-7.92-5.39-9.5
Interest & Investment Income
11.3914.5114.211.981.572.81
Earnings From Equity Investments
2.14.455.585.62-4.313.69
Other Non Operating Income (Expenses)
-3.134.884.882.573.921.08
EBT Excluding Unusual Items
51.1380.0993.17106.5293.9778.59
Gain (Loss) on Sale of Investments
-0.520.73-3.34-19-18.9899.84
Other Unusual Items
----0.92.75-
Pretax Income
30.2180.8289.8486.6277.75178.43
Income Tax Expense
20.4730.8931.9940.8831.6956.34
Earnings From Continuing Operations
9.7449.9357.8545.7446.06122.08
Minority Interest in Earnings
-0.2-6.782.87-0.5722.87-84.4
Net Income
9.5443.1560.7245.1768.9237.69
Net Income to Common
9.5443.1560.7245.1768.9237.69
Net Income Growth
-84.73%-28.93%34.42%-34.46%82.88%166.99%
Shares Outstanding (Basic)
494847454437
Shares Outstanding (Diluted)
494847464537
Shares Change (YoY)
2.59%2.20%2.94%0.44%21.24%2.87%
EPS (Basic)
0.200.911.301.001.571.03
EPS (Diluted)
0.200.901.290.991.521.01
EPS Growth
-84.99%-30.23%30.30%-34.87%50.50%158.97%
Free Cash Flow
96.9644.1739.759.1951.1145
Free Cash Flow Per Share
1.980.920.851.301.131.20
Gross Margin
10.25%13.34%15.50%17.43%22.97%21.53%
Operating Margin
2.80%4.39%6.10%9.11%12.69%11.71%
Profit Margin
0.33%2.12%4.38%3.95%8.91%5.48%
Free Cash Flow Margin
3.35%2.17%2.86%5.17%6.60%6.55%
EBITDA
118.72117.28102.36121.81115.798.85
EBITDA Margin
4.10%5.76%7.38%10.65%14.95%14.38%
D&A For EBITDA
37.4727.9317.7517.5417.5218.35
EBIT
81.2589.3584.61104.2798.1880.5
EBIT Margin
2.80%4.39%6.10%9.11%12.69%11.71%
Effective Tax Rate
67.76%38.22%35.61%47.19%40.76%31.58%
Revenue as Reported
2,8962,0351,3871,144773.92687.18
Source: S&P Global Market Intelligence. Standard template. Financial Sources.